Goate, Alison M.
Icahn School of Medicine at Mount Sinai
178 papers on CoChatORCID 0000-0002-0576-2472
Most cited papers
- Verified
Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
Dominantly Inherited Alzheimer Network, Ringman, J. M., Goate, A., Masters, C. L., Cairns, N. J., Danek, A., Graff-Radford, N., Ghetti, B., & Morris, J. C. (2014) · Current Neurology and Neuroscience Reports
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 96
- Verified
Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer's disease
Rathore, N., Ramani, S. R., Pantua, H., Payandeh, J., Bhangale, T., Wuster, A., Kapoor, M., Sun, Y., Kapadia, S. B., Gonzalez, L., et al. (2018) · PLOS Genetics
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 93
- Verified
Sex differences in the genetic predictors of Alzheimer’s pathology
Dumitrescu, L., Barnes, L. L., Thambisetty, M., Beecham, G., Kunkle, B., Bush, W. S., Gifford, K. A., Chibnik, L. B., Mukherjee, S., De Jager, P. L., et al. (2019) · Brain
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 93
- Verified
Analysis of whole genome-transcriptomic organization in brain to identify genes associated with alcoholism
Kapoor, M., Wang, J.-C., Farris, S. P., Liu, Y., McClintick, J., Gupta, I., Meyers, J. L., Bertelsen, S., Chao, M., Nurnberger, J., et al. (2019) · Translational Psychiatry
Substance Abuse Treatment and OutcomesAlcohol Consumption and Health Effects
Cited by 92
- Verified
Polygenic Scores for Major Depressive Disorder and Risk of Alcohol Dependence
Andersen, A. M., Pietrzak, R. H., Kranzler, H. R., Ma, L., Zhou, H., Liu, X., Kramer, J., Kuperman, S., Edenberg, H. J., Nurnberger, J. I., et al. (2017) · JAMA Psychiatry
Genetic Associations and EpidemiologySubstance Abuse Treatment and Outcomes
Cited by 90
- Verified
Association of childhood trauma exposure and GABRA2 polymorphisms with risk of posttraumatic stress disorder in adults
Nelson, E. C., Agrawal, A., Pergadia, M. L., Lynskey, M. T., Todorov, A. A., Wang, J. C., Todd, R. D., Martin, N. G., Heath, A. C., Goate, A. M., et al. (2009) · Molecular Psychiatry
Posttraumatic Stress Disorder ResearchChild Abuse and Trauma
Cited by 84
- Verified
Extreme cerebrospinal fluid amyloid β levels identify family with late‐onset Alzheimer's disease presenilin 1 mutation
Kauwe, J. S. K., Jacquart, S., Chakraverty, S., Wang, J., Mayo, K., Fagan, A. M., Holtzman, D. M., Morris, J. C., & Goate, A. M. (2007) · Annals of Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 84
- Verified
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1polymorphisms
Wahrle, S. E., Shah, A. R., Fagan, A. M., Smemo, S., Kauwe, J. S., Grupe, A., Hinrichs, A., Mayo, K., Jiang, H., Thal, L. J., et al. (2007) · Molecular Neurodegeneration
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 84
- Verified
Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience
Initiative, F. T. A. D. N., Ridge, P. G., Karch, C. M., Hsu, S., Arano, I., Teerlink, C. C., Ebbert, M. T. W., Gonzalez Murcia, J. D., Farnham, J. M., Damato, A. R., et al. (2017) · Genome Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 83
- Verified
Phosphorylated Tau-Aβ42 Ratio as a Continuous Trait for Biomarker Discovery for Early-Stage Alzheimer’s Disease in Multiplex Immunoassay Panels of Cerebrospinal Fluid
Harari, O., Cruchaga, C., Kauwe, J. S. K., Ainscough, B. J., Bales, K., Pickering, E. H., Bertelsen, S., Fagan, A. M., Holtzman, D. M., Morris, J. C., et al. (2014) · Biological Psychiatry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 82
- Verified
Association between alcohol consumption and Alzheimer's disease: A Mendelian randomization study
Andrews, S. J., Goate, A., & Anstey, K. J. (2020) · Alzheimer's & Dementia
Alcohol Consumption and Health EffectsDementia and Cognitive Impairment Research
Cited by 82
- Verified
Alzheimer’s disease risk variants show association with cerebrospinal fluid amyloid beta
Kauwe, J. S. K., Wang, J., Mayo, K., Morris, J. C., Fagan, A. M., Holtzman, D. M., & Goate, A. M. (2009) · neurogenetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 82
- Verified
BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer’s disease
Lim, Y. Y., Hassenstab, J., Cruchaga, C., Goate, A., Fagan, A. M., Benzinger, T. L. S., Maruff, P., Snyder, P. J., Masters, C. L., Allegri, R., et al. (2016) · Brain
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 76
- Verified
Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism
ADGC, A. D. N. I., Chapuis, J., Flaig, A., Grenier-Boley, B., Eysert, F., Pottiez, V., Deloison, G., Vandeputte, A., Ayral, A.-M., Mendes, T., et al. (2017) · Acta Neuropathologica
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 75
- Verified
Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation
Saroja, S. R., Gorbachev, K., Julia, T., Goate, A. M., & Pereira, A. C. (2022) · Proceedings of the National Academy of Sciences
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 75
- Verified
APOE4 confers transcriptomic and functional alterations to primary mouse microglia
Machlovi, S. I., Neuner, S. M., Hemmer, B. M., Khan, R., Liu, Y., Huang, M., Zhu, J. D., Castellano, J. M., Cai, D., Marcora, E., et al. (2022) · Neurobiology of Disease
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 73
- Verified
Age-Specific Incidence Rates for Dementia and Alzheimer Disease in NIA-LOAD/NCRAD and EFIGA Families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA)
Vardarajan, B. N., Faber, K. M., Bird, T. D., Bennett, D. A., Rosenberg, R., Boeve, B. F., Graff-Radford, N. R., Goate, A. M., Farlow, M., Sweet, R. A., et al. (2014) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 73
- Verified
GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia
Shade, L. M. P., Katsumata, Y., Abner, E. L., Aung, K. Z., Claas, S. A., Qiao, Q., Heberle, B. A., Brandon, J. A., Page, M. L., Hohman, T. J., et al. (2024) · Nature Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 72
- Verified
Mutations in APP have independent effects on Aβ and CTFγ generation
Hecimovic, S., Wang, J., Dolios, G., Martinez, M., Wang, R., & Goate, A. M. (2004) · Neurobiology of Disease
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 70
- Verified
Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiology
Morris, J. C., Weiner, M., Xiong, C., Beckett, L., Coble, D., Saito, N., Aisen, P. S., Allegri, R., Benzinger, T. L. S., Berman, S. B., et al. (2022) · Brain
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 68
- Verified
MAOA‐uVNTR and early physical discipline interact to influence delinquent behavior
Edwards, A. C., Dodge, K. A., Latendresse, S. J., Lansford, J. E., Bates, J. E., Pettit, G. S., Budde, J. P., Goate, A. M., & Dick, D. M. (2010) · Journal of Child Psychology and Psychiatry
Child and Adolescent Psychosocial and Emotional DevelopmentChild Abuse and Trauma
Cited by 67
- Verified
A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin
Deming, Y., Xia, J., Cai, Y., Lord, J., Holmans, P., Bertelsen, S., Holtzman, D., Morris, J. C., Bales, K., Pickering, E. H., et al. (2016) · Neurobiology of Aging
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 66
- Verified
Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups
Kaivola, K., Shah, Z., Chia, R., International LBD Genomics Consortium, Black, S. E., Gan-Or, Z., Keith, J., Masellis, M., Rogaeva, E., Brice, A., et al. (2022) · Brain
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 65
- Verified
Assessment of the Genetic Architecture of Alzheimer’s Disease Risk in Rate of Memory Decline
Del-Aguila, J. L., Fernández, M. V., Schindler, S., Ibanez, L., Deming, Y., Ma, S., Saef, B., Black, K., Budde, J., Norton, J., et al. (2018) · Journal of Alzheimer’s Disease
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 60
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free